Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Author Information
Author(s): Kim Yee Hyung, Suh Gee Young, Chung Man Pyo, Kim Hojoong, Kwon O Jung, Lim Seong Yong, Lim Si Young, Koh Won-Jung
Primary Institution: Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Hypothesis
What are the treatment outcomes for patients with isoniazid-resistant tuberculosis using various regimens?
Conclusion
The study found a 92% treatment success rate, but also highlighted concerns about treatment failure and the development of multidrug-resistant tuberculosis.
Supporting Evidence
- 92% of patients successfully completed treatment.
- 8% of patients experienced treatment failure.
- Acquired resistance to other drugs developed in some patients.
Takeaway
Doctors treated 39 patients with a type of tuberculosis that doesn't respond to a common medicine, and most of them got better, but some got worse.
Methodology
The study evaluated treatment outcomes retrospectively for 39 patients with isoniazid-resistant pulmonary TB using different treatment regimens.
Potential Biases
Potential bias due to non-random assignment of treatment regimens and lack of directly observed therapy.
Limitations
The study is limited by its retrospective design, small sample sizes for some regimens, and lack of random assignment to treatment groups.
Participant Demographics
{"sex":{"male":24,"female":12},"median_age":{"value":41,"range":"24-71"}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website